SCHEMBL5822402

SCHEMBL5822402

Cc1cc(CN(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c2nnn(C)n2)n(C)n1

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CETP P11597 18/20 0.40
TACR1 P25103 1/20 0.37
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5821109 0.83 CETP (0.40) CETPTACR1
SCHEMBL5181413 0.79 KCNH2 (0.34) CETPTACR1KCNH2
SCHEMBL5820093 0.78 CETP (0.40) CETPTACR1
SCHEMBL4184149 0.78 CETP (0.44) CETPTACR1
SCHEMBL13918433 0.78 TACR1 (0.38) CETPTACR1
SCHEMBL5823035 0.76 KCNH2 (0.35) KCNH2
SCHEMBL1601013 0.76 CETP (0.45) CETPTACR1
SCHEMBL1600532 0.76 CETP (0.43) CETPTACR1
SCHEMBL5624015 0.76 TACR1 (0.35) CETPTACR1
SCHEMBL5140629 0.76 TACR1 (0.41) CETPTACR1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1848430-A2 NOVEL BENZYLAMINE DERIVATIVES AS CETP INHIBITORS Reddy US Therapeutics, Inc. (US) 2007-10-31 EP claimed
WO-2006073973-A2 NOVEL BENZYLAMINE DERIVATIVES AS CETP INHIBITORS REDDY US THERAPEUTICS, INC. (US) 2006-07-13 WO claimed
EP-1848430-A2 NOVEL BENZYLAMINE DERIVATIVES AS CETP INHIBITORS Reddy US Therapeutics, Inc. (US) 2007-10-31 EP disclosed
WO-2006073973-A2 NOVEL BENZYLAMINE DERIVATIVES AS CETP INHIBITORS REDDY US THERAPEUTICS, INC. (US) 2006-07-13 WO disclosed